Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval

Epigenomic map reveals circuitry of 30,000 human disease regions
3 February 2021
USPSTF advises against screening for asymptomatic carotid artery stenosis
3 February 2021

Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval

The UK’s approach of leaving an interval of three months between doses of the Oxford AstraZeneca covid-19 vaccine has been supported by new data, with the Oxford University researchers also saying…

Comments are closed.